Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model

BACKGROUND: Streptococcus pneumoniae infections, which place a considerable burden on healthcare resources, can be reduced in a cost-effective manner using a 7-valent pneumococcal conjugate vaccine (PCV-7). We compare the cost effectiveness of a 13-valent PCV (PCV-13) and a 10-valent pneumococcal no...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakır, Mustafa, Türel, Özden, Topachevskyi, Oleksandr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529115/
https://www.ncbi.nlm.nih.gov/pubmed/23137037
http://dx.doi.org/10.1186/1472-6963-12-386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529115/
https://www.ncbi.nlm.nih.gov/pubmed/23137037
http://dx.doi.org/10.1186/1472-6963-12-386

Ejemplares similares